Month: April 2024

2065 posts
OceanX and Tanoto Foundation Sign MOU to Collaborate on Advancement of Ocean Education

OceanX and Tanoto Foundation Sign MOU to Collaborate on Advancement of Ocean Education

SINGAPORE, April 23, 2024 /PRNewswire/ — Global ocean exploration nonprofit, OceanX, and…
VRITIMES Announces Strategic Media Partnership with NET24News

VRITIMES Announces Strategic Media Partnership with NET24News

Singapore, April 23 – In a significant move for digital journalism and…
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era

Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era

BEIJING, April 23, 2024 /PRNewswire/ — BlueFocus (300058.SZ) disclosed its 2023 annual…
Eddid ONE and Eddid ONE USA Expand Global Coverage

Eddid ONE and Eddid ONE USA Expand Global Coverage

Now Available in 22 Countries and Regions, Connecting Global Market Pulse HONG…
Austrian maverick Trickster releases 'The National Anthem,' a St George's Day gift for King Charles III

Austrian maverick Trickster releases 'The National Anthem,' a St George's Day gift for King Charles III

LONDON, April 23, 2024 /PRNewswire/ — Trickster, the alias of Austrian musician…
Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints

Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints

Chondroitin-based supplements from Zeria Pharmaceutical launched to promote an active lifestyle SINGAPORE,…
FalconX Launches Prime Connect, A Fully Integrated Solution to Mitigate Exchange Counterparty Risk, with Deribit as First Integration

FalconX Launches Prime Connect, A Fully Integrated Solution to Mitigate Exchange Counterparty Risk, with Deribit as First Integration

Offering Includes Custody, Trading, Credit, and Off-Exchange Settlement SAN MATEO, Calif., April…
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)

SAN DIEGO and WUHAN, China, April 23, 2024 /PRNewswire/ — HanxBio today announced…